← Cockpit
239_025predictionBiotech/LongevityAGI

AI will solve back pain

Predictor: Elon Musk · ep#239 "Elon Musk: The Economy Will Be 10x the Size in 10 Years | #239" · source

Prior probability
50.0%
Current probability
45.9%
evolves via intake + LBP
Conviction
3/5
Signal quality
C
Resolution
pending
Window
2026-04-30 – 2030-06-30
Edges in / out
2 / 0
Tickers exposed
21

Prediction text

AI will solve back pain | can AI please solve back pain? That would be a huge win. And I think it will.

Verbatim quote

From episode "Elon Musk: The Economy Will Be 10x the Size in 10 Years | #239"
can AI please solve back pain? That would be a huge win. And I think it will.

Predictor: Elon Musk

κ + Brier as of 2026-05-22
κ (discount)
0.688
Brier
0.0142
excellent
Hits / Misses
1 / 0
of 3 resolved
Hit rate
33.3%
Calibration plot (stated vs observed)

Evidence about this node from Elon Musk is multiplied by κ in /api/intake. Lower κ = less weight; floors at 0.10 (effectively silenced) and caps at 1.00 (full weight).

Reference class

Not linked

This node isn't linked to a reference class. The Bayesian update applies without outside-view blending.

Probability over time

2 prob_history rows
0%25%50%75%100%prior 50%2026-04-302026-04-30
intake v2milestone miss sweeplbp propagationreference class assignedlegacy v1prior_prob (analyst seed)current = 45.9%

Milestone chain

Pre-event signals (upstream prereqs + window checkpoints) → resolution event → downstream cascades. Status/dates update from linked nodes; re-derive nightly via scripts/ops/derive_milestones.py.
Leading chain: 8 pending
  1. 2027-01-14pendingQ1 window check-in (25%)
  2. 2026-09-01 → 2027-12-31pendingFirst randomized AI-personalized therapy trial for chronic low back pain reports primary endpoint
    How: First peer-reviewed RCT of AI-personalized therapy for chronic LBP reports primary outcome (pain/function); per JMIR AI March 2026 SPOILS-class observational study evolution
    Source: deep_research_enrichedconf 55%
  3. 2027-10-01pendingQ2 window check-in (50%)
  4. 2027-01-01 → 2028-12-31pendingFDA clearance of AI-as-medical-device for back pain triage or treatment
    How: FDA 510(k) or De Novo clearance of an AI/ML SaMD specifically indicated for low back pain diagnosis, triage, or treatment selection
    Source: deep_research_enrichedconf 50%
  5. 2027-06-01 → 2029-03-31pendingMajor payer covers AI-driven back-pain therapy
    How: Medicare, UnitedHealth, Anthem, or peer payer publishes coverage policy reimbursing an AI-driven back-pain assessment or therapy at scale
    Source: deep_research_enrichedconf 45%
  6. 2028-06-17pendingQ3 window check-in (75%)
  7. 2027-06-01 → 2029-11-30pendingNeuralink or competitor BCI receives FDA approval for chronic-pain indication
    How: Neuralink, Synchron, or peer BCI receives FDA Breakthrough Device or full approval for a chronic-pain indication that includes neuropathic back pain
    Source: deep_research_enrichedconf 30%
  8. 2028-06-01 → 2029-11-30pendingPopulation-scale outcomes evidence: AI back-pain interventions show >30% improvement vs SOC
    How: Multi-site, n>5,000 study (RCT pooled or registry) demonstrates AI-driven back-pain interventions yield >30% improvement in functional/pain outcomes vs standard of care; defines 'solving' the condition
    Source: deep_research_enrichedconf 30%
  9. 2029-03-04pendingAI will solve back pain

No downstream cascades — this prediction is a leaf in the dependency graph.

What if this resolves?

Clamp this prediction TRUE or FALSE and run a counterfactual Gibbs sample. Surfaces the predictions whose marginals shift most under that assumption.
(live posterior: 46%)

Click a button to clamp this prediction and run a Gibbs sample. Returns the predictions whose marginals shift most. ~30s per run; ideal for stress-testing "if X resolves, what else moves?"

Evidence chain

Every probability update with full Bayesian provenance — chronological, latest first
LBP2026-04-30T16:39:51Z45.9%-1.4pp
Network propagation: 47.3% → 45.9%
5-iter LBP, residual 0.00825 · damping 0.5, w_intrinsic 0.5 · method lbp_v2 · run 0c8a4ea3
LBP2026-04-30T02:18:57Z47.3%-2.7pp
Network propagation: 50.0% → 47.3%
5-iter LBP, residual 0.00825 · damping 0.5, w_intrinsic 0.5 · method lbp_v1 · run 592311ef

Network propagation neighbors

Top edges sorted by latest LBP cross-impact
All propagation →

Top incoming (parents)

Edges that influence THIS node's belief

KindNodeTheir probP(c|s=T)P(c|s=F)Δ implied
killerTK01
AGI Capability Plateau (2026-27 Training Stall)
15.0%0.0500.500-0.026
killerTK03
AI Regulatory Moratorium (EU/US Capability Freeze)
10.0%0.0500.500-0.004

Top outgoing (children)

Predictions THIS node influences

No outgoing edges.

Ticker exposure

21 ticker(s) linked

Beneficiaries (14)

SOUNNVDAGTLBAIBBAITCEHYAMZNBABAGOOGLIBMMETAMSFTORCLSHOP

Adverse (7)

ACNCTSHFRSHCHGGIBMINFYPEGA

Prerequisites (2)

Predictions that must hit first
TypePredTitleDomainLag
killerTK01AGI Capability Plateau (2026-27 Training Stall)——
killerTK03AI Regulatory Moratorium (EU/US Capability Freeze)——

Dependents (0)

Predictions enabled by this
TypePredTitleDomainLag
No dependents

Raw metadata

From Thesis_Timeline_v1.0_FINAL workbook
{
  "nia": false,
  "url": "https://www.youtube.com/watch?v=N5KCm_55xeQ",
  "mode": "PREDICTION",
  "role": "Guest-CEO",
  "context": "can AI please solve back pain? That would be a huge win. And I think it will.",
  "verbatim": "can AI please solve back pain? That would be a huge win. And I think it will.",
  "conv_cues": "I think it will",
  "direction": "HAPPEN",
  "timeframe": "future, unspecified",
  "conv_level": "MEDIUM",
  "milestones": [
    {
      "kind": "quartile_checkpoint",
      "label": "Q1 window check-in (25%)",
      "status": "pending",
      "weight": 0.05,
      "ordinal": -8,
      "source_id": null,
      "expected_date": "2027-01-14",
      "observed_date": null
    },
    {
      "kind": "llm_pre_event",
      "label": "First randomized AI-personalized therapy trial for chronic low back pain reports primary endpoint",
      "source": "deep_research_enriched",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -7,
      "source_id": null,
      "confidence": 0.55,
      "source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12978536/",
      "expected_date": "2027-05-02",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2027-12-31",
        "from": "2026-09-01"
      },
      "measurement_criterion": "First peer-reviewed RCT of AI-personalized therapy for chronic LBP reports primary outcome (pain/function); per JMIR AI March 2026 SPOILS-class observational study evolution"
    },
    {
      "kind": "quartile_checkpoint",
      "label": "Q2 window check-in (50%)",
      "status": "pending",
      "weight": 0.05,
      "ordinal": -6,
      "source_id": null,
      "expected_date": "2027-10-01",
      "observed_date": null
    },
    {
      "kind": "llm_pre_event",
      "label": "FDA clearance of AI-as-medical-device for back pain triage or treatment",
      "source": "deep_research_enriched",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -5,
      "source_id": null,
      "confidence": 0.5,
      "source_url": "https://www.nature.com/articles/s41746-020-0303-x",
      "expected_date": "2028-01-01",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2028-12-31",
        "from": "2027-01-01"
      },
      "measurement_criterion": "FDA 510(k) or De Novo clearance of an AI/ML SaMD specifically indicated for low back pain diagnosis, triage, or treatment selection"
    },
    {
      "kind": "llm_pre_event",
      "label": "Major payer covers AI-driven back-pain therapy",
      "source": "deep_research_enriched",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -4,
      "source_id": null,
      "confidence": 0.45,
      "source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10551394/",
      "expected_date": "2028-04-30",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2029-03-31",
        "from": "2027-06-01"
      },
      "measurement_criterion": "Medicare, UnitedHealth, Anthem, or peer payer publishes coverage policy reimbursing an AI-driven back-pain assessment or therapy at scale"
    },
    {
      "kind": "quartile_checkpoint",
      "label": "Q3 window check-in (75%)",
      "status": "pending",
      "weight": 0.05,
      "ordinal": -3,
      "source_id": null,
      "expected_date": "2028-06-17",
      "observed_date": null
    },
    {
      "kind": "llm_post_event",
      "label": "Neuralink or competitor BCI receives FDA approval for chronic-pain indication",
      "source": "deep_research_enriched",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -2,
      "source_id": null,
      "confidence": 0.3,
      "source_url": "https://applyingai.com/2026/04/transforming-brain-computer-interfaces-neuralinks-2026-breakthroughs-and-market-dynamics/",
      "expected_date": "2028-08-30",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2029-11-30",
        "from": "2027-06-01"
    
... (truncated)